科研之友
微信
新浪微博
Facebook
分享链接
摘要
A new Fc-silent anti-human CD154 domain antibody synergizes with conventional immunosuppressants to control renal transplant rejection in nonhuman primates without evidence of thromboembolism, raising the prospect of its combination with approved costimulation-blocking agents in the clinic. See the article from Kim etal on page 1182.
- 出版日期2017-5
